Archive - SMC COVID-19 research tracking

hybrid immunity, electronic health records, long Covid, BA.2.75, wastewater monitoring, rapid diagnostics

7 hr ago

Moderna vs Pfizer effectiveness, long Covid, symptom resurgence, mask effectiveness, BA.2.75

Aug 4

New vaccines, reinfection risks, infectious period, infection risk in children, pandemic origin

Jul 28

Vaccine effectiveness in children, and in males vs females, Omicron's selective advantages, pre-existing immunity, alleles that increase Covid risk, NZ…

Jul 21

Vaccine effectiveness, pan-coronavirus vaccine, immune system dampening, post-pandemic behaviours, BA.2.75

Jul 7

Vaccine effectiveness in kids, viral shedding, BA.5 characteristics, long Covid, aerosols, masks

Jun 30

Immune evasion, long Covid, multiple infections, infection risks, ventilation

Jun 23

Omicron & immune evasion, nasal vaccine, re-infection rates, public health communications

Jun 16

BA.4 & BA.5, new Moderna booster, Paxlovid, long Covid, new therapies

Jun 9

Comparing vaccines, hybrid immunity, Omicron variants, Paxlovid, mask effectiveness

Jun 2

Long covid, waning immunity, Omicron variants, hepatitis, antiviral therapies

May 26

long covid, hepatitis risks, new therapies and diagnostic tests, estimating health costs

May 19

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts